Now Available:
Download the podcast of Dr. Troum's presentation

With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

MSK Video Report:


Dr. Orrin Troum presents "eMRI in Clinical Practice: A Rheumatologist's Perspective" at the ISEMIR Conference

Arthritis: FDA Launches Major Investigation of Cancer Risk in Children Taking TNF Blockers
The FDA is investigating a possible link between TNF blockers and cancer in children and young adults...

Bones: Less Osteoporosis Care, More Hip Fractures Seen in Europe vs Other Countries
European doctors are less likely to screen for or treat osteoporosis, and hip fracture rates in Europe are higher than in North America or Australia, according to baseline data from the ongoing Global Longitudinal registry of Osteoporosis in Women (GLOW)...

Imaging: Case Series Adds Support for Routine PET in Polymyalgia Rheumatica
Routine PET might be a useful option in patients with steroid-resistant polymyalgia rheumatica (PMR)...

Arthritis: B-Cell Subset May Identify RA Patients at Risk for Relapse After Rituximab
A memory B-cell subset that could be readily monitored from peripheral blood samples might help identify RA patients who need early re-treatment with rituximab to prevent RA relapse...

BioPharm Business: Jazz Pharmaceuticals Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate (Xyrem) to Treat FMS
Jazz Pharmaceuticals, a specialty pharmaceutical company, announced completion of enrollment in the first of two phase III pivotal clinical trials of JZP-6 (sodium oxybate, Xyrem) for the treatment of fibromyalgia...

BioPharm Business: Genta Announces Phase I Clinical Trial Results for G4544, an Oral Formulation of Gallium Nitrate, a Novel Potent Drug for Bone Disease
Results from the phase I clinical trial of G4544 showed that the drug was well-tolerated and that blood levels were achieved in a range known to be clinically bioactive...

BioPharm Business: Novartis' Once-Yearly Reclast Injection 5 mg Receives Revised US Label; Indication to Include Prevention of Fractures After a Hip Fracture
The FDA has broadened the indication for once-yearly Reclast (zoledronic acid) for postmenopausal osteoporosis to include the prevention of new clinical fractures in patients who have recently had a low-trauma hip fracture...

Click here to remove your e-mail address from our mailing list. For questions and comments regarding this newsletter please contact .